Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

The therapy, called photobiomodulation or “red light” therapy, can reduce the risk of vision loss and slow progression of the ...

Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...

There are various factors that may potentially increase the risk of developing AMD, such as advancing age (over 50); having a ...

Alkeus Pharmaceuticals’ study results from Gildeuretinol shows significant trend in slowing geographic atrophy: Cambridge, Massachusetts Friday, October 25, 2024, 10:00 Hrs [IST ...

Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated ... injections of anti-VEGF drugs. The current status ...

Amgen will launch its biosimilar version of Regeneron's blockbuster eye care drug Eylea following a U.S. appeals court ruling ...

By squeezing Regeneron’s Eylea, eye disease drug Vabysmo has become one of the biggest growth drivers for Roche. | Despite ...

While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.

CHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration ...

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...